Theriva Biologics (TOVX) Non Operating Income (2010 - 2026)
Theriva Biologics (TOVX) posted Non Operating Income of $78,000 for Q2 2026, up 5.4% from $74,000 a year earlier but down 6.0% from the prior quarter.
Theriva Biologics (TOVX) Non Operating Income (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Non Operating Income at Theriva Biologics was $307,000, down 33.4% year-over-year; for FY2025, it came in at $312,000, down 55.0% from FY2024.
- Annual Non Operating Income shows a five-year compound annual growth rate of 48.0% (FY2020 to FY2025).
- In prior years, Theriva Biologics' Non Operating Income was $693,000 in FY2024 (-51.9%), $1.44 million in FY2023 (+206.2%), $471,000 in FY2022 and $6,000 in FY2021 (-86.4%).
- Quarterly Non Operating Income has run from a low of -$21,000 in Q1 2022 to a high of $388,000 in Q3 2023 over five years.
- On a year-over-year basis, Non Operating Income increased in 1 of the last eight quarters, with an average decline of 42.2%.
- The strongest year-over-year quarter for Non Operating Income in the past five years was Q2 2022, with growth of 750.0%; the weakest was Q1 2025, with a decline of 59.0%.
- According to Business Quant data, Non Operating Income for the three prior quarters was $83,000 (Q1 2026), $67,000 (Q4 2025) and $79,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Theriva Biologics | 10.56 Mn | 10.56 Mn | - | 78,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 78,000.00 |
| Mar 31, 2026 | 83,000.00 |
| Dec 31, 2025 | 67,000.00 |
| Sep 30, 2025 | 79,000.00 |
| Jun 30, 2025 | 74,000.00 |
| Mar 31, 2025 | 93,000.00 |
| Dec 31, 2024 | 133,000.00 |
| Sep 30, 2024 | 161,000.00 |
| Jun 30, 2024 | 172,000.00 |
| Mar 31, 2024 | 227,000.00 |
| Dec 31, 2023 | 308,000.00 |
| Sep 30, 2023 | 388,000.00 |
| Jun 30, 2023 | 377,000.00 |
| Mar 31, 2023 | 370,000.00 |
| Dec 31, 2022 | 314,000.00 |
| Sep 30, 2022 | 161,000.00 |
| Jun 30, 2022 | 17,000.00 |
| Mar 31, 2022 | -21,000.00 |
| Dec 31, 2021 | 2,000.00 |
| Sep 30, 2021 | 2,000.00 |
Theriva Biologics Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=TOVX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "TOVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=TOVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();